It was a pleasure to meet Rumana Hussain (Liverpool University Hospital, Liverpool, UK) to discuss the results of her study into the mortality risks of genetically high-risk uveal melanomas, and the implications for future treatment paradigms.
Questions
- What is known about the mortality risks of genetically high-risk uveal melanomas (UM)? (00:20)
- What were the aims and design of your study? (02:06)
- What were the study findings? (04:25)
- What are the implications of these findings in terms of future treatment paradigms? (05:28)
- What questions remain unanswered and what future studies are planned? (06:05)
Speaker Disclosure: Rumana Hussain has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of EURETINA 2021.
